CAS 60142-96-3 Pharmaceutical Powder 99% Gabapentin for Seisure Epilepsy

CAS 60142-96-3 Pharmaceutical Powder 99% Gabapentin for Seisure Epilepsy

Min.Order / FOB Price:Get Latest Price

100 Gram	FOB Price: USD 1.0000

100 Gram

FOB Price: USD 1.0000

Min.Order :100 Gram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

gabapentin price gabapentin powder gabapentin

Quick Details

Appearance:white crystalline powder
Application:Pharmaceutical Intermediate
PackAge:Foil Bag, According to Client's Requirement
ProductionCapacity:10000|Kilogram|Week
Storage:store in cool and dry place
Transportation:FedEx DHL EMS or by Sea

Superiority:

1, High quality with competitive price:

1) Standard:BP/USP/EP/Enterprise standard

2) All Purity≥99%

3) We are manufacturer and can provide high quality products with factory price.

2, Fast and safe delivery

1) Parcel can be sent out in 24 hours after payment.Tracking number available

2) Secure and discreet shipment.Various transportation methods for your choice.

3) Customs pass rate ≥99%

4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,

and we have stock in there for transferring.

3,We have clients throughout the world.

1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.

2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.

14) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.

Details:

Gabapentin (GPN), marketed under the brand name Neurontin among others, is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless leg syndrome. In epilepsy it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, post-herpetic neuralgia, and central neuropathic pain. A 2017 review of its use for diabetic neuropathy and postherpetic neuralgia found that about 15% of people have a meaningful benefit.